Caffeine Protects Against Anticonvulsant-Induced Impaired Neurogenesis in the Developing Rat Brain

Area of Science:

• Neuroscience
• Developmental Biology
• Pharmacology

Background:

• Phenobarbital is a first-line antiepileptic for neonatal seizures, while caffeine treats apnea in preterm infants.
• Experimental data suggest anticonvulsants like phenobarbital may be toxic to the developing brain.
• Caffeine has demonstrated neuroprotective effects in both animal models and preterm infants.

Purpose of the Study:

• To investigate the interaction between phenobarbital and caffeine on the developing hippocampus in neonatal rats.
• To characterize the effects of these drugs, administered separately or together, on postnatal neurogenesis.

Main Methods:

• Neonatal rats were administered phenobarbital (50 mg/kg) and/or caffeine (10 mg/kg) from postnatal day 4 to 6.
• The study assessed the impact on the proliferative capacity of the dentate gyrus.
• Expression of neuronal markers (DCX, calretinin, NeuN), transcription factors (Pax6, Sox2, Tbr1/2, Prox1), and neurotrophins (NGF, BDNF, NT-3) was analyzed.

Main Results:

• Phenobarbital significantly decreased proliferative capacity and reduced the expression of neuronal markers, transcription factors, and neurotrophins.
• The negative effects of phenobarbital on neurogenesis were largely ameliorated by co-administration of caffeine.
• Caffeine alone transiently reduced proliferation and some neuronal markers but increased neurotrophins and transcription factors.

Conclusions:

• Phenobarbital administration during a critical window of brain development impairs neuronal development in neonatal rats.
• Co-administration of caffeine can partially prevent the neurotoxic effects of phenobarbital.
• These findings highlight the potential neuroprotective role of caffeine when used with phenobarbital in vulnerable neonatal populations.